News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,180 Results
Type
Article (86987)
Company Profile (704)
Press Release (766487)
Multimedia
Podcasts (152)
Webinars (20)
Section
Business (232873)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91134)
Employer Resources (199)
FDA (18208)
Job Trends (17372)
News (396956)
Policy (39840)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56977)
ALS (123)
Alzheimer's disease (1614)
Antibody-drug conjugate (ADC) (192)
Approvals (18163)
Artificial intelligence (409)
Autoimmune disease (39)
Automation (20)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (408)
Cancer (3205)
Cardiovascular disease (258)
Career advice (3542)
Career pathing (34)
CAR-T (214)
CDC (43)
Cell therapy (590)
Cervical cancer (25)
Clinical research (74486)
Collaboration (1155)
Company closure (3)
Compensation (733)
Complete response letters (39)
COVID-19 (2915)
CRISPR (70)
C-suite (389)
Cystic fibrosis (124)
Data (3258)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (384)
Diagnostics (6995)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (193)
Drug pricing (156)
Drug shortages (36)
Duchenne muscular dystrophy (160)
Earnings (97831)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131632)
Executive appointments (925)
FDA (20085)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (42)
Gene therapy (463)
GLP-1 (946)
Government (5286)
Grass and pollen (7)
Guidances (221)
Healthcare (20921)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (42)
Infectious disease (3120)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (130)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (602)
Leadership (27)
Legal (10139)
Liver cancer (85)
Longevity (12)
Lung cancer (449)
Lymphoma (224)
Machine learning (13)
Management (65)
Manufacturing (478)
MASH (104)
Medical device (14750)
Medtech (14756)
Mergers & acquisitions (22610)
Metabolic disorders (978)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2409)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (497)
Opinion (292)
Ovarian cancer (107)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (204)
Partnered (25)
Patents (340)
Patient recruitment (187)
Peanut (55)
People (65796)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22977)
Phase II (32342)
Phase III (24362)
Pipeline (1787)
Policy (252)
Postmarket research (3554)
Preclinical (10380)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (544)
Real estate (7402)
Recruiting (76)
Regulatory (27322)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (940)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (102)
Last 7 days (565)
Last 30 days (1995)
Last 365 days (33827)
2025 (19719)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50597)
Australia (8892)
California (8023)
Canada (2487)
China (742)
Colorado (342)
Connecticut (357)
Delaware (215)
Europe (116132)
Florida (1198)
Georgia (274)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1133)
Massachusetts (6142)
Michigan (280)
Minnesota (501)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2252)
New Mexico (31)
New York (2237)
North Carolina (1267)
North Dakota (10)
Northern California (3484)
Ohio (259)
Oklahoma (17)
Oregon (48)
Pennsylvania (1719)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2985)
Tennessee (132)
Texas (1243)
United States (30265)
Utah (233)
Virginia (221)
Washington D.C. (80)
Washington State (705)
West Virginia (4)
Wisconsin (87)
854,180 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference
August 1, 2025
·
1 min read
Press Releases
Natera Highlights Latest Prospera™ Data at WTC 2025; 16 Abstracts Including Five Oral Presentations
August 1, 2025
·
6 min read
Press Releases
Fulgent Reports Second Quarter 2025 Financial Results
August 1, 2025
·
14 min read
Press Releases
Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference
August 1, 2025
·
5 min read
Press Releases
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025
August 1, 2025
·
1 min read
Press Releases
Spine BioPharma Announces Topline Results from Phase 3 MODEL Trial For SB-01 (vicatertide) In Chronic Low Back Pain Associated with Degenerative Disc Disease
August 1, 2025
·
6 min read
Register: Bridging Formulation & Device: Integrated Supply Chain Strategies for US Pharma Manufacturing
Join us for a high-level discussion on overcoming pharmaceutical supply chain challenges through end-to-end integration.
August 1, 2025
Press Releases
Large And Small-scale Bioprocessing Market Size Expected to Hit USD 248.12 Billion by 2034
August 1, 2025
·
1 min read
Press Releases
Oncology Drug Discovery Market 2025 Trends and Key Players
August 1, 2025
·
1 min read
Earnings
Regulatory Roadblocks Blemish Regeneron’s Otherwise Strong Q2
Delays in the decision dates for high-dose Eylea are linked to issues at a Catalent-owned facility. Once these are resolved, Regeneron expects “to receive favorable action” on these applications, CEO Leonard Schleifer told investors.
August 1, 2025
·
2 min read
·
Tristan Manalac
1 of 85,418
Next
